GB1056214A - Compositions containing lobeline sulphate - Google Patents
Compositions containing lobeline sulphateInfo
- Publication number
- GB1056214A GB1056214A GB671265A GB671265A GB1056214A GB 1056214 A GB1056214 A GB 1056214A GB 671265 A GB671265 A GB 671265A GB 671265 A GB671265 A GB 671265A GB 1056214 A GB1056214 A GB 1056214A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphate
- compositions
- present
- compositions containing
- lobeline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- GRZMOSSVIPFGFF-GNJLJDPWSA-N 2-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone;sulfuric acid Chemical compound OS(O)(=O)=O.C1([C@@H](O)C[C@H]2N([C@H](CCC2)CC(=O)C=2C=CC=CC=2)C)=CC=CC=C1.C1([C@@H](O)C[C@H]2N([C@H](CCC2)CC(=O)C=2C=CC=CC=2)C)=CC=CC=C1 GRZMOSSVIPFGFF-GNJLJDPWSA-N 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 230000003444 anaesthetic effect Effects 0.000 abstract 2
- 229960005274 benzocaine Drugs 0.000 abstract 2
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 241000208125 Nicotiana Species 0.000 abstract 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract 1
- 229920001213 Polysorbate 20 Polymers 0.000 abstract 1
- SYCBXBCPLUFJID-UHFFFAOYSA-N Pramoxine hydrochloride Chemical compound Cl.C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 SYCBXBCPLUFJID-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 229940124326 anaesthetic agent Drugs 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000010692 aromatic oil Substances 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 abstract 1
- 229960000228 cetalkonium chloride Drugs 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 abstract 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 abstract 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract 1
- 229940019974 pramoxine hydrochloride Drugs 0.000 abstract 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 abstract 1
- 230000000391 smoking effect Effects 0.000 abstract 1
- 229960001462 sodium cyclamate Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Sprayable compositions, for topical oral application, comprise an aqueous solution containing lobeline sulphate and a topically active local anaesthetic. Suitable such anaesthetics are ethyl aminobenzoate (benzocaine), lidocaine, or pramoxine hydrochloride. Other active ingredients may be present, such as a non-toxic bactericide, preferably a quarternary ammonium salt such as cetyl dimethylbenzyl ammonium chloride; a surface active agent such as polyoxyethylene sorbitan monolaurate; and aromatic oils, such as oil of pepermint. Also present may be ethanol, glycerol, buffers such as dibasic sodium phosphate, sweetening agents (e.g. saccharine or sodium cyclamate) and colouring substances. The compositions are useful for reducing the desire for smoking tobacco.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36928464A | 1964-05-21 | 1964-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1056214A true GB1056214A (en) | 1967-01-25 |
Family
ID=23454837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB671265A Expired GB1056214A (en) | 1964-05-21 | 1965-02-16 | Compositions containing lobeline sulphate |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1056214A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995011678A1 (en) * | 1993-10-28 | 1995-05-04 | Dynagen, Inc. | Use of nicotine substitutes for the treatment of nicotine withdrawal |
| US5414005A (en) * | 1993-10-28 | 1995-05-09 | Dynagen, Inc. | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation |
| US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
-
1965
- 1965-02-16 GB GB671265A patent/GB1056214A/en not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
| WO1995011678A1 (en) * | 1993-10-28 | 1995-05-04 | Dynagen, Inc. | Use of nicotine substitutes for the treatment of nicotine withdrawal |
| WO1995011679A1 (en) * | 1993-10-28 | 1995-05-04 | Dynagen, Inc. | Use of lobeline for the treatment of nicotine withdrawal |
| US5414005A (en) * | 1993-10-28 | 1995-05-09 | Dynagen, Inc. | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8402550D0 (en) | N-SUBSTITUTED DERIVATE OF MORANOLINE | |
| ES477653A1 (en) | New amino sugar derivatives, their preparation and amylase inhibitors containing them. | |
| DE2962527D1 (en) | Hydroxyethyl azoles, process for their preparation and their use in medicaments | |
| CO4130326A1 (en) | NEW DERIVATIVES OF 2-CIANO-1,3-DIONA, COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THEIR PREPARATION AND USE AS HERBICIDES | |
| KR920702217A (en) | Malaria Therapeutic Composition | |
| ES2052603T3 (en) | DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM. | |
| PH16119A (en) | New hydroxypropyl-triazole compound,their composition and medicinal use | |
| KR840000236A (en) | How to minimize water loss in topical formulations in mammals | |
| ES2032955T3 (en) | 5-CHLORINE-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE SODIUM SODIUM SALT. | |
| NZ196700A (en) | Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives | |
| ZA818499B (en) | Agents for combating circulatory illnesses and their use | |
| ATE59632T1 (en) | DIHYDRODIBENZOCYCLOHEPTYLIDENETHYLAMINE DERIVATIVES | |
| ATE40822T1 (en) | AROMATASE INHIBITORS 1,2,3-TRIAZOLE-1-YL, TETRAZOLE-1-YL AND TETRAZOLE-2-YL COMPOUNDS. | |
| GB1056214A (en) | Compositions containing lobeline sulphate | |
| ES327089A1 (en) | Dithiosemicarbazones | |
| AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
| ES8101624A1 (en) | Spiroketalins and their applications | |
| JPS5626814A (en) | Antibacteria agent and its use | |
| ES450299A1 (en) | Amides of pyrrolidinoethylamine which can be used in treatment of coughs | |
| JPS5573661A (en) | Fluorenyllazolylmethyllcarbinol compound* its manufacture and its use as drug | |
| ES454289A1 (en) | Analgesic (3-micotinamido-N(quinolyl) anthranilates and method of use | |
| GB1012585A (en) | New compositions for use in acne and like conditions | |
| JPS59210040A (en) | Method for stabilizing hinokitiol | |
| CH411825A (en) | Process for the preparation of 1: 3: 5-tricyano-3-phenyl-pentane, its derivatives and their use to form nematoid compositions for crop protection | |
| JPS5513228A (en) | Sterilization composition |